1
Nov
2023
Investing in the Future of Medicine: Reid Huber on The Long Run
Today’s guest on the The Long Run is Reid Huber. He’s a partner at Third Rock Ventures in Boston. Third Rock is known in biotech as one of the venture firms that creates new companies that seek to turn groundbreaking science into new medicines. Since its founding in 2007, Third Rock has put together a portfolio of 62 companies that... Read More
1
Nov
2023
Gate Bioscience, Backed by Versant, A16Z, Arch, Gets $60M to Block Protein Secretion
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.